Design of novel tripyridinophane-based Eu(III) complexes as efficient luminescent labels for bioassay applications

Covalently Immobilizable Tris(Pyridino)-Crown Ether for Separation of Amines Based on Their Degree of Substitution

A great number of biologically active compounds contain at least one amine function. Appropriate selectivity can only be accomplished in a few cases upon the substitution of these groups, thus functionalization of amines generally results in a mixture of them. The separation of these derivatives with very similar characteristics can only be performed on a preparative scale or by applying pre-optimized HPLC methods. A tris(pyridino)-crown ether was designed and synthetized for overcoming these limitations at a molecular level. It is demonstrated, that this selector molecule is able to distinguish protonated primary, secondary and tertiary amines by the formation of reversible complexes with different stabilities. This degree of substitution-specific molecular recognition of amines opens the door to develop separation processes primarily focusing on the purification of biologically active compounds in a nanomolar scale.

Versatile Macrocyclic Platform for the Complexation of [natY/90Y]Yttrium and Lanthanide Ions

We report a macrocyclic ligand (H₃L⁶) based on a 3,6,10,13-tetraaza-1,8(2,6)-dipyridinacyclotetradecaphane platform containing three acetate pendant arms and a benzyl group attached to the fourth nitrogen atom of the macrocycle. The X-ray structures of the YL⁶ and TbL⁶ complexes reveal nine coordination of the ligand to the metal ions through the six nitrogen atoms of the macrocycle and three oxygen atoms of the carboxylate pendants. A combination of NMR spectroscopic studies (¹H, ¹³C, and ⁸⁹Y) and DFT calculations indicated that the structure of the YL⁶ complex in the solid state is maintained in an aqueous solution. The detailed study of the emission spectra of the EuL⁶ and TbL⁶ complexes revealed Ln³⁺-centered emission with quantum yields of 7.0 and 60%, respectively. Emission lifetime measurements indicate that the ligand offers good protection of the metal ions from surrounding water molecules, preventing the coordination of water molecules. The YL⁶ complex is remarkably inert with respect to complex dissociation, with a lifetime of 1.7 h in 1 M HCl. On the other hand, complex formation is fast (∼1 min at pH 5.4, 2 × 10^–5 M). Studies using the ⁹⁰Y-nuclide confirmed fast radiolabeling since [⁹⁰Y]YL⁶ is nearly quantitatively formed (radiochemical yield (RCY) > 95) in a short time over a broad range of pH values from ca. 2.4 to 9.0. Challenging experiments in the presence of excess ethylenediaminetetraacetic acid (EDTA) and in human serum revealed good stability of the [⁹⁰Y]YL⁶ complex. All of these experiments combined suggest the potential application of H₃L⁶ derivatives as Y-based radiopharmaceuticals.

A new versatile asymmetric ligand based on an 18-membered macrocycle possessing three acetate pendant arms and a benzyl moiety provides fast complexation with both ^natY(III) and ⁹⁰Y(III), as well as slow dissociation kinetics. A detailed structural study in the solid state and in solution evidences nona coordination of the metal ion by the ligand, offering good protection from solvent water molecules. These favorable properties make this ligand an attractive candidate to develop yttrium-based radiopharmaceuticals.